Prolonged Gastrointestinal Manifestations After Recovery From COVID-19
B. Joseph Elmunzer(University of Michigan–Ann Arbor), Douglas A. Drossman(Rome Foundation), Olafur S. Palsson(University of North Carolina at Chapel Hill), Jan Tack(KU Leuven), Nauzer Forbes(University of Calgary), Collins O. Ordiah(Medical University of South Carolina), Robin B. Mendelsohn(Memorial Sloan Kettering Cancer Center), Ian Sloan(Washington University in St. Louis), Gokul Bala(The Ohio State University Wexner Medical Center), Caroline G. McLeod, Emad Qayed(Unknown), Olga C. Aroniadis(Stony Brook University Hospital), Swati Pawa(Wake Forest University), Zachary L. Smith(Washington University in St. Louis), Andrew Canakis(Boston University), Benjamin L. Bick(Indiana University School of Medicine), William M. Tierney(Richard M. Fairbanks Foundation), Jason R. Taylor(University of Manchester), Ambreen A. Merchant(Emory University), Magnus Simrén(Sahlgrenska University Hospital), Ali Zakaria(Ascension Providence Hospital), Christian Davis(University of Colorado Anschutz Medical Campus), Morgan A. Sendzischew Shane(University of Miami), Johannah M. Ruddy(University of North Carolina at Chapel Hill), Harsh K. Patel(Ochsner Medical Center)
Cited by 24
Related Papers
Bowel Disorders
|Gastroenterology|2016|2.8k
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k
Irritable bowel syndrome
|Nature Reviews Disease Primers|2016|981